Optellum and Coreline Soft have announced plans to integrate AI to support lung nodule detection and management across international markets and multiple disease areas.

Distalmotion has received 510(k) clearance from the FDA for ventral hernia repair with its Dexter robotic surgery system.

Beyond supporting its VitaSmart system's US rollout, Bridge to Life also intends to use the funds to expand its portfolio and scale its global operations.

Abbott and Google Health have collaborated to bring ongoing glucose monitoring and AI-driven health guidance to Google Health users.

Teledyne Technologies has entered a definitive agreement to purchase Varex Imaging in a cash transaction valued at nearly $1.1bn.

Zepto's grant from NIAID follows its fungal infection panel's receipt of breakthrough device designation from the FDA in June 2026.

The lion’s share of Alcon’s profits came from its surgical segment at around $1.6bn, indicative of an 8% uptick YoY.

Acarix has secured regulatory approval for its CADScor system in the UAE, a step that paves the way for the device's commercial availability.

Collette Health has entered into a partnership with VirtuAlly to provide virtual care programmes for hospitals and health systems.

GlobalData analysts Dr Andrew Thompson and Charlie Whelan will discuss key challenges impacting the diabetes technology supply chain in a webinar on 18 August.

Resmed highlighted that factors including suspended ventilator sales and ongoing macro uncertainty had contributed to its tempered FY27 outlook.